Assessment of treated wastewater infiltration in Bright Angel Wash and the potential for contaminants of emerging concern influencing spring water quality along the South Rim of the Grand Canyon in Grand Canyon National Park, Arizona

Abstract

In April 2021, a synoptic study conducted by the U.S. Geological Survey (USGS) and National Park Service (NPS) identified wastewater-related contaminants of emerging concern (CECs) in springs along the South Rim of the Grand Canyon. These springs are located north of Bright Angel Wash, an ephemeral channel that receives treated effluent from the South Rim Wastewater Treatment Plant (SRWTP). Although water flows southwest and away from the canyon, there is evidence that treated wastewater is finding a flow path along fractures associated with the Bright Angel Fault back to water sources along the South Rim. The CECs identified during the April 2021 sampling included several per- and polyfluoroalkyl substances (PFAS) and pharmaceutical compounds. The PFAS compounds detected only consisted of perfluoroalkyl acids, and these were only detected at Bright Angel Wash (treated wastewater), Monument Spring, and upper Horn Bedrock Spring. The other five sampled springs (the Salt Creek, Horn East Alluvium, Garden, Pumphouse, and Pipe Springs) had no detections of PFAS compounds. The five perfluoroalkyl acids detected at Monument Spring (in descending order of concentration) were perfluorobutanesulfonic acid (PFBS), perfluoropentanoic acid, perfluorooctanoic acid, perfluorohexanoic acid, and perfluorooctanesulfonic acid. Only the short-chained PFBS and perfluorobutanoic acid compounds were detected at the upper Horn Bedrock Spring. All the same perfluoroalkyl acids were found at Bright Angel Wash, except for PFBS. Monument Spring was the only spring to have detections of pharmaceuticals. The two pharmaceuticals detected at the highest concentrations at Monument Spring were diphenhydramine (antihistamine) and carbamazepine (anticonvulsant or anti-epileptic drug). The other detected pharmaceuticals included (in descending order of concentration) fluconazole (antifungal), sulfamethoxazole (antibiotic), metformin (diabetes drug), tramadol (opioid analgesic), and venlafaxine (antidepressant and nerve pain medication). The same pharmaceuticals were detected in the wastewater at Bright Angel Wash but in greater concentrations. No CEC concentrations measured at Monument Spring exceeded any drinking water standards or human health benchmarks; however, most of the compounds detected have no regulatory standards. Studies of the ecological effects of these compounds show that some of the compounds detected can have endocrine and physiological effects, but generally, effects were observed at concentrations multiple orders of magnitude greater than what was measured during the April 2021 study. Data from 1980 through 2022 retrieved from the Water Quality Portal were combined with data from the one-time synoptic sampling in April 2021 to assess the usefulness of other analytes for identifying a wastewater connection to South Rim springs. Most of the historical water chemistry data showed a statistical difference between samples collected within and east of the Garden Creek watershed and samples collected from locations in watersheds to the west of Garden Creek, including the Horn Creek, Salt Creek, Monument Creek, and Hermit Creek watersheds, which roughly align with the Bright Angel Fault. Most of the historical analytes were inconclusive as potential wastewater tracers, but nitrate, chloride, and gadolinium data possibly support the historical contribution of wastewater to Monument Spring.